top of page

Ongoing Clinical Trials in
Complement 3 Glomerulopathy

IPTACOPAN


Excessive local activation and dysregulation of the alternative complement pathway in the glomeruli can cause excessive...

List of Updated Clinical Trials for C3G Glomerulopathy

bottom of page